§ EQUITY
USDMGX
METAGENOMI THERAPEUTICS INC
USD
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
15 increased/new, 15 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | n/a | n/a |
| Renaissance Technologies | 788K | 0.0% | +25% |
| Catalio Capital Management, LP | 529K | 0.1% | ±0% |
| Peapod Lane Capital LLC | 517K | 0.6% | +4% |
| TWO SIGMA INVESTMENTS, LP | 497K | 0.0% | +13% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 396K | 0.0% | ±0% |
◇ AC INTELLIGENCE
Top institutional owners for MGX as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER72.8% · 29 holders
SYSTEMATIC / QUANT10.7% · 3 holders
PASSIVE / INDEX7.8% · 2 holders
DEALER / BANK5.9% · 9 holders
TACTICAL / MACRO2.5% · 2 holders
QUALITY / COMPOUNDER0.3% · 3 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for MGX in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention MGX yet.